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recombination, relatively specific defects were found
Hiroshi Nakajima,* Xiu-Wen Liu,²
Anthony Wynshaw-Boris,³ Louis A. Rosenthal,§
Kazunori Imada,* David S. Finbloom,§
Lothar Hennighausen,² and Warren J. Leonard*‖
*Laboratory of Molecular Immunology
corresponding to defective signaling in response to in-National Heart, Lung, and Blood Institute
terferons, interleukin-12 (IL-12), and IL-4/IL-13, respec-²Laboratory of Biochemistry and Metabolism
tively, even though in the case of Stat1, a large numberNational Institute of Diabetes
of cytokines and growth factors have been reported toand Digestive and Kidney Diseases
activate this STAT protein.³Laboratory of Genetic Disease Research
Stat5 was originally identified as a mammary glandNational Human Genome Research Institute
factor induced by prolactin (Wakao et al., 1994). Subse-National Institutes of Health
quently, this protein was renamed Stat5a when a sec-Bethesda, Maryland 20892
ond, homologous gene, denoted Stat5b, was identified§Division of Cytokine Biology
(Azam et al., 1995; Liu et al., 1995; Mui et al., 1995b; LinCenter for Biologics Evaluation and Research
et al., 1996). Both Stat5a and Stat5b are activated notFood and Drug Administration
only by prolactin but also by a wide range of otherBethesda, Maryland 20892
cytokines, including growth hormone, erythropoietin,
thrombopoietin, IL-3, granulocyte-macrophage colony-
stimulating factor (GM-CSF), IL-5, IL-2, IL-7, IL-9, and
Summary IL-15 (Schindler and Darnell, 1995). Nevertheless, the
specificities of their actions are demonstrated by the
Stat5a was identified as a prolactin-induced transcrip- observations that Stat5a-deficient (Stat5a2/2) mice ex-
tion factor but also is activated by other cytokines, hibit defective prolactin-related functions, with impaired
including interleukin-2 (IL-2) and IL-7. We have now lobuloalveolar outgrowth of mammary epithelium during
analyzed the immune system of Stat5a-deficient mice. pregnancy, resulting in defective lactation (Liu et al.,
Stat5a2/2 splenocytes exhibited defective IL-2±induced 1997), whereas Stat5b2/2 mice exhibit defective growth
expression of the IL-2 receptor a chain (IL-2Ra), a similar to that found in Laron dwarfism (Udy et al., 1997).
protein that together with IL-2Rb and the common These different phenotypes underscore the distinct
cytokine receptor g chain (gc) mediates high-affinity roles of Stat5a and Stat5b. Recently, bone marrow±
derived macrophages from Stat5a2/2 mice were ana-IL-2 binding. Correspondingly, Stat5a2/2 splenocytes
lyzed and shown to exhibit defective GM-CSF±inducedexhibited markedly decreased proliferation to IL-2, al-
proliferation and gene expression (Feldman et al., 1997).though maximal proliferation was still achieved at IL-2
We have now analyzed the immunological propertiesconcentrations high enough to titrate intermediate-
in Stat5a2/2 mice. Given the role of IL-7 in T and B cellaffinity IL-2Rb/gc receptors. Thus, defective Stat5a
development (Peschon et al., 1994; von Freeden-Jeffryexpression results in diminished proliferation by an
et al., 1995) and of IL-2 in the proliferation of peripheralindirect mechanism, resulting from defective receptor
T cells (Smith, 1988), we were particularly interested inexpression. Correspondingly, we show that Stat5a is
analyzing whether lymphoid development is normal inessential for maximal responsiveness to antigenic
Stat5a2/2 mice and whether T cells exhibit normal prolif-stimuli in vivo, underscoring the physiological impor-
eration. We found that although thymic developmenttance of IL-2±induced IL-2Ra expression.
was relatively normal, splenocytes were diminished in
number and their proliferation in response to low con-Introduction
centrations of IL-2 was diminished due to a defect in IL-
2±induced expression of IL-2 receptor a chain (IL-2Ra).Signal transducers and activators of transcription (STAT)
However, concentrationsof IL-2 sufficient to titrate inter-
proteins are cytosolic latent transcription factors that
mediate affinity IL-2 receptors (which contain IL-2Rb
are rapidly activated following cellular exposure to in-
and the common cytokine receptor g chain [gc] but notterferons, cytokines, or growth factors (reviewed by IL-2Ra) could induce maximal proliferation, indicating
Schindler and Darnell, 1995; Ihle, 1996; Horvath and that Stat5a2/2 lymphocytes were not defective in their
Darnell, 1997; Leonard and O'Shea, 1998). A total of intrinsic ability to proliferate. Given that a number of
seven different STAT proteins have been identified. STATs have been implicated in proliferation, these data
Much investigation has centered on the degree of speci- reveal an important instance in which the role of a STAT
ficity for each STAT protein and the extent to which protein in proliferation is indirect. Moreover, they pro-
STATs contribute to proliferation versus differentiation. vide evidence for the physiological importance of IL-2±
At least some STATs exhibit selective actions for one induced up-regulation of IL-2Ra expression.
or a limited number of cytokines (reviewed by Leonard,
1996; Horvath and Darnell, 1997). For example, in mice Results
Because Stat5a is activated in response to IL-7 (Lin et‖ To whom correspondence should be addressed (e-mail: wjl@helix.
nih.gov). al., 1995) and IL-7 is known to be vital for T cell and B
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Figure 1. T Cell and B Cell Development in
Stat5a2/2 Mice
(A) Cellularity of thymus of 5- to 8-week-old
wild-type and Stat5a2/2 mice.
(B and C) Flow cytometric analysis of thymo-
cytes from 6-week-old mice. (B) Expression
of CD4 versus CD8 on total thymocytes using
anti-CD8-Cy-Chrome and anti-CD4-FITC. (C)
Expression of CD25 versus CD44 on double-
negative thymocytes. Single- and double-
positive cells were gated out using anti-CD4-
FITC and anti-CD8-FITC. Double-negative
cells were analyzed using anti-CD44-Cy-
Chrome and anti-CD25-PE.
(D) Stat5a2/2 mice tended to express slightly
diminished numbers of splenocytes. The
mice analyzed were 5±8 weeks old.
(E±H) Flow cytometric analysis of splenocytes
from 6-week-old mice. Cells were stained with
anti-B220 Cy-Chrome versus anti-TCRb (H57)-
FITC (E), anti-CD8 Cy-Chrome versus anti-
CD4 FITC (F), anti-TCRgd FITC versus anti-
TCRb Cy-Chrome (gated on CD31 cells) (G),
or anti-B220 Cy-Chrome versus anti-IgM
FITC (H).
cell development (Peschon et al., 1994; von Freeden- normal (data not shown), in contrast to the activated
phenotype found in IL-22/2 (Sadlack et al., 1995) andJeffry et al., 1995), we first evaluated whether lymphoid
development was normal in Stat5a2/2 mice. Analysis IL-2Ra2/2 mice (Willerford et al., 1995). T cells bearing
gd TCR appeared to be diminished in Stat5a2/2 miceof the thymus revealed essentially normal cellularity in
these mice (Figure 1A; 85.1 6 41.8 3 106 for wild-type (Figure 1G). Based on B220 versus immunoglobulin M
(IgM) staining, B cells in the spleen (Figure 1H) and bonemice vs. 83.7 6 36.1 3 106 for Stat5a2/2 mice). In addi-
tion, flow cytometric analysis revealed essentially indis- marrow (data not shown) exhibited relatively normal
maturation. Cells of the monocyte/macrophage (Mac-11tinguishable CD4/CD8 staining (Figure 1B), normal IL-2Ra
(CD25)/CD44 staining within double-negative CD42 cells) and granulocytic (Gr-11 cells) lineages also were
present in normal numbers (data not shown). The pres-CD82 thymocytes (Figure 1C), and normal expression
of the CD69 activation antigen on both CD41CD82 ence of normal T cell populations in thymus and of nor-
mal B cell populations in both bone marrow and spleenand CD42CD81 single-positive thymocytes (data not
shown). In contrast to the normal thymic cellularity in underscored the ability of IL-7 to act as a thymocyte
maturation factor as well as a pre±B cell growth factorStat5a2/2 mice, the number of splenocytes was mod-
estly decreased (Figure 1D; 70.0 6 14.5 3 106 cells/ in the absence of Stat5a.
We next analyzed STAT activation in Stat5a2/2 cells.spleen for wild-type mice vs. 52.8 6 17.1 3 106 cells/
spleen for Stat5a2/2 mice, P , 0.001). Flow cytometric As shown in Figure 2A, IL-7±induced STAT DNA binding
was reduced in Stat5a2/2 thymocytes. Analogously,analysis of splenocyte populations revealed relatively
similar T:B cell ratios (based on T cell receptor [TCR] IL-2 could activate STAT DNA binding activity in
Stat5a2/2 splenocytes, and again less binding activityab and B220 expression) inwild-type and Stat5a2/2 mice
(Figure 1E). Among the T cells, the CD4:CD8 ratios were was seen than in wild-type mice (Figure 2B). Supershift-
ing with an antiserum specific for Stat5 proteins con-similar (Figure 1F) and theexpression of activation mark-
ers (CD69, CD62L, and CD25 [IL-2Ra]) on T cells were firmed that the complex induced in Stat5a2/2 cells
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Figure 2. Impaired STAT Activation in Stat5a2/2
Thymocytes and Splenocytes
(A) Electromobility shift assays(EMSAs) using
extracts from thymocytes that were stimu-
lated with 5 ng/ml (330 pM) of murine recom-
binant IL-7 for 15 min. Whole-cell extracts
were prepared and EMSAs were performed
as described in Experimental Procedures.
(B) EMSAs using extracts from activated
splenocytes. Anti-CD3±stimulated spleno-
cytes were rested in RPMI 1640 media con-
taining 10% FCS and 2 mM glutamine for 10
hr and stimulated with 2 nM human recombi-
nant IL-2 for 15 min. Whole-cell extracts were
prepared and EMSAs were performed.
(C) Splenocytes were activated with phyto-
hemagglutinin and then either not stimulated
(control, CTRL) or stimulated with IL-2, IL-7,
IL-15, or interferon-a (IFN-a). Extracts were
then prepared and EMSAs were performed.
(D) Western blotting of whole-cell extracts
from thymocytes treated with IL-7 (lanes 1
and 2) and anti-CD3±preactivated spleno-
cytes treated with IL-2 (lanes 3 and 4) with
antisera for Stat5a, Stat5b, and Stat3.
contained Stat5b (Figures 2A and 2B). These results Stat3 (Figure 2D). In some Stat5a2/2 mice, splenocytes
expressed normal levels of Stat5b protein (Figure 2D),indicated that Stat5b DNA binding activity is not depen-
dent on the presence of Stat5a. Interestingly, like IL-2, whereas in others, Stat5b was diminished (data not
shown; see Discussion).IL-15 also induced much less STAT binding activity in
the Stat5a2/2 splenocytes than in wild-type splenocytes, Since Stat5a has been shown to interact with gluco-
corticoid receptor (Stocklin et al., 1996), we next ana-whereas IL-7±induced STAT binding activity was less
impaired (Figure 2C). Since the IL-2 and IL-15 receptors lyzed the dexamethasone-induced death of thymocytes
in Stat5a2/2 mice. Dexamethasone is known to induceboth share the IL-2 receptor b chain (Bamford et al.,
1994; Giri et al., 1994), which mediates Stat5 docking apoptosis of thymocytes, and IL-7 could prevent the
dexamethasone-induced death of CD41CD82 matureand activation (Fujii et al., 1995; Gaffen et al., 1995; Lin
et al., 1995; Friedmann et al., 1996), it is logical that thymocytes in wild-type mice (Figure 3, left). The induc-
tion of death by dexamethasone and its prevention bySTAT protein activation in response to these cytokines
would be similar. IL-7±induced Stat5 activation instead IL-7 were also seen in Stat5a2/2 mice at a level similar
to that observed in wild-type mice (Figure 3, right). Theseis mediated by the IL-7 receptor a chain, which contains
in its cytoplasmic domain a tyrosine-based motif that is results indicate that Stat5a is not required for dexameth-
asone-induced death and that at least some of the sig-similar but slightly different from that found in IL-2Rb
(Lin et al., 1995). It is possible that the differences in the nals induced by IL-7 for preventing dexamethasone-
induced death are not absolutely dependent on Stat5a.sequences of the IL-2Rb and IL-7Ra motifs could be
responsible for an altered efficiency for recruitment and Given the importance of IL-2 in T cell proliferation and
the ability of IL-2 to activate Stat5a potently (Beadling,activation of Stat5b. In contrast to the diminished STAT
protein activation in response to IL-2, IL-7, and IL-15, et al., 1994; Fujii et al., 1995; Gaffen et al., 1995; Gilmour
et al., 1995; Hou et al., 1995; Lin et al., 1995; Wakao etthere was normal STAT protein activation in response
to interferon-a (Figure 2C), which is known to activate al., 1995; Lin et al., 1996), we next examined T cell prolif-
eration in the spleen. Substantial proliferation of freshprimarily complexes containing Stat1 and Stat2 (Schind-
ler and Darnell, 1995), confirming that the Stat5a2/2 splenocytes was observed in response to anti-CD3 (Ta-
ble 1). In this and other experiments, although the differ-splenocytes were capable of a full response to a differ-
ent stimulus. Stat5a2/2 mice express normal levels of ence was not statistically significant, cells from the
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Table 1. Splenocyte Proliferation
Genotype RPMI Anti-CD3
1/1 1299 6 260 74,516 6 7888
1/1 635 6 25 55,258 6 3797
1/1 756 6 69 92,967 6 5792
2/2 219 6 54 65,564 6 22,753
2/2 180 6 64 47,859 6 19,847
2/2 125 6 49 25,860 6 4582
Splenocytes from Stat5a2/2 mice proliferated in response to anti-
CD3. Shown is the mean [3H]thymidine uptake 6 SD of triplicate
wells.
Figure 3. Stat5a2/2 Mice Exhibit Normal Dexamethasone-Induced
Death of CD41CD82 Thymocytes and Normal Prevention of This
Death by IL-7
Thymocytes (1 3 105) from Stat5a2/2 or wild-type mice were cultured signal through intermediate affinity receptors (compare
with murine recombinant IL-7 (5 ng/ml) and/or dexamethasone (Dex) histograms e and j in each panel). For example, Stat5a2/2
(2 3 1028 M). Eighteen hours later, cell viability was determined as CD81 T cells exhibited approximately 40%±45% of the
described in Experimental Procedures. Shown are means 6 SDfrom
wild-type level of IL-2Ra after stimulation with anti-CD3three mice.
(448.3 vs. 1051.1 mean fluorescent intensity [Figure 4A,
histogram g vs. b]). However, when these activated cells
were washed and stimulated with IL-2 for an additionalStat5a2/2 mice tended to exhibit less proliferation in
response to anti-CD3 than did cells from the wild-type 48 hr, IL-2Ra expression was approximately 10%±15%
of wild-type (mean fluorescent intensity of 154.8 formice. Since anti-CD3±induced IL-2 production in
Stat5a2/2 mice was normal (data not shown), we specu- Stat5a2/2 mice vs. 1295.6 for wild-type mice) (Figure 4A,
histogram j vs. e). A similar though less dramatic defectlated that a partial defect in proliferation might result
from diminished cellular sensitivity to IL-2. Indeed, when was seen in CD41 T cells (Figure 4B). Expression of
another activation marker (CD69), which is not affectedStat5a2/2 splenocytes that had been preactivated with
anti-CD3 were stimulated with IL-2, proliferation was by IL-2 stimulation, was equivalently expressed in wild-
type and Stat5a-deficient mice under all treatment con-markedly diminished at low concentrations of IL-2 but
was much more similar to that seen in wild-type mice ditions (Figure 4C). Expression of another inducible
gene, IL-2Rb, was also examined and similar levels ofat high concentrations of IL-2 (Table 2). The finding that
high concentrations of IL-2 were required for achieving IL-2Rb were observed in wild-type and Stat5a2/2 mice
under all conditions (Figure 4D, see legend). The dimin-normal levels of proliferation suggested that IL-2Ra ex-
pression might be compromised in the Stat5a2/2 mice, ished IL-2Ra protein expression corresponded to dimin-
ished levels of IL-2Ra mRNA (Figures 5A and 5B). Inthereby decreasing the number of high affinity IL-2 re-
ceptors. This hypothesis was consistent with a Stat5 view of the decreased expression of IL-2Ra, we also
examined the expression of other IL-2±induced genesbinding site in an IL-2 response element in the IL-2Ra
gene (Sperisen et al., 1995; John et al., 1996; Lecine et (Figure 5). Although levels of both IL-2Rb and Bcl-2
mRNA were diminished, their expression was more nor-al., 1996). Whereas anti-CD3±induced levels of IL-2Ra
protein expression were only modestly diminished in mal than that seen for IL-2Ra. Expression of IL-2, which
is not regulated by IL-2, was not diminished.Stat5a2/2 CD81 (Figure 4A) and CD41 (Figure 4B) splenic
T cells as compared to wild-type cells (compare histo- Finally, we analyzed the clonal expansion of T cells
in Stat5a2/2 mice using the bacterial superantigengrams b and g in each panel), there was a substantial
defect in IL-2±induced IL-2Ra expression even though staphylococcal enterotoxin B (SEB) (Kawabe and Ochi,
1991). In this system, following SEB administration, thewe used a high enough concentration of IL-2 (2 nM) to
Table 2. Proliferation of Anti-CD3±Stimulated Splenocytes
IL-2
Experiment Genotype RPMI 10 pM 100 pM 1000 pM
Experiment 1 1/1 118,640 6 9348 136,327 6 1830 180,671 6 9760 311,122 6 9380
1/1 116,856 6 6619 108,786 6 4790 169,265 6 6590 255,882 6 8377
2/2 36,585 6 1078 39,200 6 1312 78,419 6 4866 218,462 6 9273
2/2 22,226 6 975 30,711 6 1687 72,722 6 2733 248,836 6 6234
2/2 38,087 6 5777 31,080 6 620 70,013 6 5875 178,744 6 8609
2/2 55,113 6 4868 54,022 6 1939 93,471 6 1941 266,789 6 8281
Experiment 2 1/1 222,223 6 3471 215,156 6 5000 230,787 6 5281 282,810 6 11,912
2/2 30,928 6 3609 36,498 6 10048 70,080 6 4273 219,775 6 16,638
2/2 48,648 6 4091 53,896 6 5013 113,095 6 2383 358,991 6 9360
2/2 67,267 6 4141 78,171 6 6004 111,651 6 3651 286,339 6 12,485
Impaired proliferation of anti-CD3±stimulated Stat5a2/2 splenocytes at low concentration of IL-2. Wild type and Stat5a2/2 splenocytes were
stimulated in Falcon 3003 plates coated with 10 mg/ml anti-CD3 mAb for 48 hr and washed twice with PBS, and cells (1 3 105/well) were
cultured with the indicated concentrations of human recombinant IL-2 for 24 hr with [3H]thymidine added during the final 10 hr.
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Figure 4. Impaired IL-2Ra Expression on Activated CD81 and CD41
T Cells
(A and B) Splenocytes were from wild-type (histograms a±e) or
Stat5a2/2 (histograms f±j) mice. Freshly isolated splenocytes (histo-
grams a and f) were stimulated in Falcon 3003 plates coated with
10 mg/ml anti-CD3 MAb for 48 hr (histograms b and g); washed
twice with PBS; and cultured with 5 mg/ml anti-IL-2 (clone S4B6,
PharMingen) (histograms c and h), medium alone (histograms d and
i), or 2 nM human recombinant IL-2 (histograms e and j) for another
48 hr. At every stage of culture (fresh, anti-CD3 stimulation for 48
hr, anti-CD3 stimulation for 48 hr followed by another 48 hr with or
without IL-2), cells were stained with anti-IL-2Ra (CD25) FITC, anti-
CD4 PE, and anti-CD8 Cy-Chrome and analyzed on a FACSort.
Shown are IL-2Ra expression and fluorescent intensity (mean) on
CD81 (A) or CD41 (B) T cells from a representative mouse of more
than ten mice analyzed.
(C) CD69 expression on CD41 or CD81 T cells from wild-type or
Stat5a2/2 mice.
(D) IL-2Rb expression on CD41 or CD81 T cells from wild-type or
Stat5a2/2 mice. In (C) and (D), the four superimposed histograms
correspond to staining with control antibody (broken line) or anti-
CD69 (C) or anti-IL-2Rb (D) (lines a, b, e, f, g, and j correspond to
the treatments described above for [A] and [B]). Note that surface
expression of IL-2Rb (D) was induced by anti-CD3 in both CD41
and CD81 Tcells, but additional IL-2 treatment increased expression
of IL-2Rb only in CD41 T cells. This presumably resulted from a
difference in these cell types in the balance between IL-2±induced
production and IL-2±mediated internalization of IL-2Rb.
T cells bearing Vb8 T cell receptors are specifically acti- The expectedcompensatory changes were seen inVb61
T cells in both wild-type and Stat5a2/2 mice (Figures 6Cvated and expanded in vivo and subsequently deleted
by apoptosis. As shown in Figure 6A, there was little, if and 6D). Because mice lacking IL-2 (Kneitz et al., 1995)
or IL-2Ra (Willerford et al., 1995) are defective in SEB-any, SEB-induced expansion of Vb81 CD81 T cells in
Stat5a2/2 mice (P , 0.01), whereas SEB-induced expan- induced deletion of Vb81 T cells, we analyzed SEB-
induced deletion in Stat5a2/2 mice. Of note, no detect-sion of Vb81 CD41 T cells occurred albeit less potently
than that seen in wild-type mice (p 5 0.052, Figure 6B). able defect was found in SEB-induced deletion in
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Figure 5. Impaired IL-2Ra mRNA Expression
in Activated Splenocytes
(A) Anti-CD3±stimulated splenocytes were
cultured with or without 2 nM human recom-
binant IL-2 for 10 hr. Cells were washed with
PBS, and RNA was extracted using Trizol re-
agent. Northern blots were hybridized with
the indicated genes.
(B) The intensities of bands were quantified
by densitometry and their intensities were
normalized relative to the amount of G3PDH
hybridization. Shown are representative data
from four mice.
Stat5a2/2 mice at day 8 (Figures 6A and 6B). Consistent including antigens/mitogens and certain cytokines, such
as IL-2 (Leonard et al., 1984, 1994; Depper et al., 1985;with this finding, SEB could increase apoptosis of Vb81
T cells as evaluated by staining with Annexin V (Figure reviewed by Smith, 1988). Analysis of the 59 regulatory
region of the IL-2Ra gene has revealed the presence7A) and induce Fas expression on Vb81 T cells (Figure
7B) to a similar level in Stat5a2/2 and wild-type mice. of at least three important regulatory regions. Whereas
positive regulatory regions I and II are essential for mito-This Fas induction was functional, since Fas-mediated
death was enhanced by SEB treatment in both Vb81 gen-induced IL-2Ra expression (John et al., 1995), they
are insufficient for IL-2±induced regulation of the IL-2RaCD41 T cells (Figures 7C and 7E) and Vb81 CD81 T cells
(Figures 7D and 7F) with a similar efficiency in Stat5a2/2 gene. Instead, a third region, positive regulatory region
III, which binds both Stat5 and Elf-1, forms a potent IL-2mice and wild-type littermates. This was seen with either
agonistic anti-Fas monoclonal antibody (MAb) (clone response element in both the murine (Sperisen et al.,
1995) and human (John et al., 1996; Lecine et al., 1996)Jo2, Figures 7C and 7D) or soluble Fas ligand (FasL)
(Figures 7E and 7F). These results indicate that Stat5a IL-2Ra genes. Indeed, mutations of tyrosines in IL-2Rb
that are required for Stat5 docking and activation areis required for normal levels of SEB-induced expansion
(presumably by allowing IL-2±induced IL-2Ra expres- required for IL-2Ra induction (Friedmann et al., 1996;
Ascherman et al., 1997). Our data now establish thatsion). In contrast, Stat5a-mediated signaling is not re-
quired for maintaining normal levels of SEB-induced Stat5a is vital for normal IL-2±induced IL-2Ra expression
but not for anti-CD3±induced IL-2Ra expression. Thedeletion.
finding that anti-CD3±induced IL-2Ra expression was
diminished in Stat5a2/2 mice may be explained by theDiscussion
fact that anti-CD3 stimulation also induces IL-2 produc-
tion; thus, anti-CD3 has both ªdirectº TCR-mediatedThere are three classes of IL-2 receptors, binding IL-2
with low (Kd 5 1028 M), intermediate (Kd 5 1029 M), and effects and ªindirectº IL-2±induced effects on IL-2Ra
induction in normal mice, but in the Stat5a2/2 mice,high (Kd 5 10211 M) affinities. Low-affinity IL-2 receptors
contain only IL-2Ra; intermediate-affinity receptorscon- these latter signals are defective. Moreover, our data
indicate that proliferation at physiological levels of IL-2tain IL-2Rb and gc; and high-affinity receptors contain
all three chains. Only the intermediate and high-affinity is dependent on IL-2±induced IL-2Ra expression and
suggest that antigen-mediated induction of IL-2Ra,receptors can transduce signals in response to IL-2.
Consistent with this observation, the heterodimerization without IL-2±induced maintenance of IL-2Ra levels, is
insufficient for normal proliferation or expansion of Tof IL-2Rb and gc is both necessary and sufficient for
IL-2 signaling (Nakamura etal., 1994; Nelson et al., 1994). cells in vivo.
Considerable discussion has centered on the role ofAlthough signaling can occur in the absence of IL-2Ra,
IL-2Ra is vital for normal immune function, as demon- STATs in proliferation (Leonard, 1996). Both Stat4 (Kaplan
et al., 1996b; Thierfelder et al., 1996) and Stat6 (Kaplanstrated by the autoimmunity, inflammatory bowel dis-
ease, and premature death exhibited by IL-2Ra2/2 mice et al., 1996a; Shimoda et al., 1996; Takeda et al., 1996)
knockout mice exhibit diminished proliferation in re-(Willerford et al., 1995) and by the severe combined
immunodeficiency in a patient with IL-2Ra deficiency sponse to IL-12 and IL-4, respectively, although the
mechanism(s) for these effects have remained unclear.(Sharfe et al., 1997). Presumably, IL-2Ra is required to
convert intermediate-affinity receptors into high-affinity In the case of Stat62/2 mice, IL-4Ra expression is dimin-
ished, making it unclear whether the lack of Stat6 hadreceptors, thus conferring a 100-fold increase in binding
affinity for IL-2, and allowing efficient cellular respon- a direct or indirect effect on proliferation. Various studies
have either suggested no role (Quelle et al., 1996) orsiveness to the low concentrations of IL-2 that are physi-
ologically produced in vivo. some role (Goldsmith et al., 1995; Mui et al., 1995a;
Friedmann et al., 1996) for Stat5 in proliferation. OurIL-2Ra expression is induced by a variety of stimuli,
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Figure 6. Defective SEB-Induced Expansion of Vb81 T Cells in
Stat5a2/2 Mice
Wild-type or Stat5a2/2 mice were injected with SEB as described
in Experimental Procedures. The percentage Vb8 (A and B) and Vb6
(C and D) were then determined for CD8 (A and C) and CD4 (B and
D) populations of T cells.
data clarify that at least for IL-2 signaling, the defect in
proliferation in Stat5a2/2 lymphocytes is indirect and is
based on diminished IL-2Ra expression, since maximal
proliferation in vitro could be achieved at levels of IL-2
sufficient to titrate IL-2Rb/gc intermediate affinity recep-
tors. The defect in SEB-induced clonal expansion of
Vb81 T cells in Stat5a2/2 mice, particularly among the
CD81 T cells, indicates that Stat5a is vital for clonal
expansion in vivo, at least for the CD81 T cells (the cells
in which we observed a greater defect in IL-2±induced
IL-2Ra expression [Figure 4]).
Not only is IL-2Ra expression important for maximal
T cell proliferation; it also appears to play a role in sensi-
Figure 7. Stat5a-Deficient MiceExhibit Normal Fas-Mediated Deathtizing T cells to activation-induced cell death, since this
(A) Similar levels of annexin V staining in wild-type and Stat5a-function is defective in IL-2Ra±deficient mice (Willerford
deficient Vb81CD41 T cells in mice treated with PBS (top) or SEBet al., 1995). Presumably, because of this defect of acti-
(bottom) for 5 days.
vation-induced cell death, IL-2Ra±deficient mice exhibit (B) Basal (PBS) and SEB-induced levels of Fas expression was
lymphadenopathy and autoimmune disease. It is there- similar in wild-type and Stat5a2/2 mice. Shown is anti-Fas staining
on Vb81CD41 T cells in mice treated with PBS or SEB for 5 days.fore noteworthy that the Stat5a2/2 mice (at least until
(C±F) Mice were pretreated for 72 hr with PBS (open bars) or SEB4 months of age, the oldest mice we have examined)
(filled bars) before cells were harvested as described in Experimentaldevelop neither lymphadenopathy nor an activated phe-
Procedures. (C and D) Shown are means 6 SD of the percentage
notype of T cells (data not shown), as is typically found induced cell death in Vb81 CD41 (C) and Vb81 CD81 (D) T cells
in the IL-2Ra±deficient mice (Willerford et al., 1995). The treated with anti-Fas MAb (clone Jo2). (E and F) Shown are means 6
finding that the Stat5a2/2 mice are more normal than IL- SD of percentage induced cell death in Vb81 CD41 (E) and Vb81 (F)
T cells treated with soluble FasL.2Ra2/2 mice might be explained by their retention of
relatively normal anti-CD3±induced IL-2Ra expression.
Stat5b expression was diminished in some Stat5a2/2
mice. This could suggest that Stat5b expression can Stat5a expression itself was responsible for diminished
induction of IL-2Ra in response to IL-2.be influenced by Stat5a or by a Stat5a-regulated gene
product, and it was possible that diminished Stat5b ex- Given that Stat5a is activated by IL-7 (Lin et al., 1995),
it was striking that no obviousdevelopmental abnormali-pression could contribute to the defects observed. How-
ever, even Stat5a2/2 mice with normal levels of Stat5b ties were found in the immune systems of Stat5a2/2
mice, even though IL-72/2 and IL-7Ra2/2 mice exhibitexhibited the same defects, indicating that defective
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Experimental Proceduresmarkedly compromised T cell and B cell development
(Peschon et al., 1994; von Freeden-Jeffry et al., 1995).
MiceIn addition, although IL-7 is known to play a role in All animals used for these experiments wereF2 orF3 animals derived
IL-2Ra expression in double-negative thymocytes (Zu- from Stat5a heterozygous crosses of mixed background (129
niga-Pflucker et al., 1996), Stat5a2/2 mice exhibit normal SvEv 3 NIH Black Swiss or 129 SvEv 3 BALB/c) animals. All experi-
ments were carried out under protocols approved by National Insti-IL-2Ra expression in these cells. Thus, Stat5a is not
tutes of Health Animal Use and Care Committees and followed therequired for these actions of IL-7. We have also shown
National Institutes of Health guidelines ªUsing Animals in Intramuralthat the absence of Stat5a had little effect on the ability
Research.º
of IL-7 to prevent dexamethasone-induced apoptosis.
Given that Stat5a and the glucocorticoid receptor can
Flow Cytometric Analyses
physically interact (Stocklin et al., 1996), it might have Cells from the thymus and spleen were stained and analyzed on a
been expected that dexamethasone-induced apoptosis FACSort (Becton Dickinson, San Jose, CA) using CELLQuest soft-
ware (Cao et al., 1995). For direct staining, the following conjugatedand its prevention by IL-7 would be impaired in Stat5a2/2
antibodies were purchased from PharMingen (San Diego, CA): anti-mice. Thus, either the Stat5a-glucocorticoid receptor
TCRab fluorescein isothiocyanate (FITC) and Cy-chrome (H57±597interaction is not important for this apoptosis or there
to TCRb); anti-TCRgd FITC (GL3), anti-CD3e phycoerythrin (PE) (145±
are redundant pathways. Since IL-4 can also exhibit a 2C11), anti-CD4 FITC, PE, and Cy-Chrome (H129.19); anti-CD8 FITC,
protective effect similar to that of IL-7 in preventing PE, and Cy-Chrome (53±6.7); anti-IL-2Ra (CD25) FITC (7D4), anti-
dexamethasone-induced apoptosis (Migliorati et al., IL-2Ra PE (3C7), anti-CD44 Cy-Chrome (IM7), anti-CD45R (B220) Cy-
Chrome (RA3±6B2), anti-CD69 PE (H1.2F3), anti-IgM FITC (R6±60.2),1993), even though IL-4 activates Stat6 instead of Stat5
anti-IL-2Rb FITC (TM-b1), anti-TCR Vb6-FITC, and PE (RR4±7); andproteins, it is clear that protective effects against dexa-
anti-TCR Vb8.1,2 FITC and PE (MR5±2).methasone-induced apoptosis are not strictly depen-
dent on a particular STAT protein.
Annexin V StainingTherefore, from the analysis of Stat5a-deficient mice,
After cells were stained with anti-CD4 Cy-Chrome and anti-Vb8 PE
we can draw several conclusions. First, we provide the and washed twice with phosphate-buffered saline (PBS) containing
first example in which the mechanism of defective prolif- 1% bovine serum albumin (BSA), cells were stained with annexin V
FITC (R & D Systems) according to the manufacturer's instructions.eration in a STAT-deficient system is clearly an indirect
Cells were analyzed on a FACSort.effect, based on the regulation of expression of a com-
ponent of a cytokine receptor chain (IL-2Ra). Defective
Dexamethasone-Induced Cell Death Assay of ThymocytesStat5a expression did not cause a defect in the intrinsic
An in vitro cell death assay of thymocytes was performed by modi-proliferative potential of peripheral T cells; instead, it
fying the method of Negishi et al. (1995). In brief, thymocytes (1 3
caused a defect IL-2±induced IL-2Ra expression, which 105) from Stat5a2/2 or wild-type mice were cultured in RPMI 1640
in turn caused defective T cell proliferation in vitro at media supplemented with 10% fetal bovine serum (FBS), 2 mM
glutamine, and antibiotics. Where indicated, murine recombinantlow levels of IL-2. Second, the finding that superantigen-
IL-7 (R & D Systems)was added at 5 ng/ml (330pM), anddexametha-induced T cell expansion in vivo was also defective
sone was used at 2 3 1028 M. Eighteen hours later, cells weredemonstrates the importance of IL-2±induced IL-2Ra
harvested and stained with anti-CD4 FITC and anti-CD8 PE, and
expression in vivo. Third, given the severe defect in cell viability was determined using propidium iodide (PI, 5 mg/ml,
thymic and B cell development in mice deficient in IL-7 Sigma) and a flow cytometer without gating. Cells were analyzed
in triplicate. The percentage survival of CD41CD82 (CD4 single-or IL-7Ra (and in mice deficient in gc [Cao et al., 1995;
positive) cells was calculated as (number of viable CD4 single-posi-DiSanto et al., 1995; Ohbo et al., 1996] or Jak3 [Nosaka
tive cells cultured with each additive/number of viable CD4 single-et al., 1995; Park et al., 1995; Thomis et al., 1995]), our
positive cells cultured in medium alone) 3 100.
data indicate that Stat5a is not an absolutely essential
downstream signaling molecule for IL-7 in lymphoid de-
SEB-Induced Expansion and Deletion of Vb81
velopment, even though IL-7 potently activates Stat5a. T Cells In Vivo
Fourth, our data provide in vivo evidence that there Mice 3±4 months old were injected intraperitoneally with PBS or 50
mg of staphylococcal enterotoxin B (SEB, Sigma) and then sacrificedare two mechanisms by which the IL-2Ra gene can
on days 3 and 8. Splenocytes were stained with anti-CD4 PE andbe activated (one by anti-CD3, largely independent of
anti-CD8 Cy-Chrome plus either anti-Vb8.1,2 FITC or anti-Vb6 FITCStat5a, and one by IL-2, largely dependent on Stat5a).
and then analyzed on a FACSort.
Considering the data reported by Willerford et al. (1995)
on the phenotype of IL-2Ra±deficient mice, we can now Fas-Mediated Cell Death of Splenic T Cells
conclude that there are important physiological roles Stat5a2/2 or littermate control mice were injected with PBS or 50
for both mechanisms of activation of the IL-2Ra gene. mg of SEB. Mice were sacrificed 72 hr later and sensitivity to Fas-
mediated cell death was analyzed in two ways. First, splenocytesFifth, the finding that both IL-2 and Stat5a-deficient
were cultured for 6 hr with 5 mg/ml agonistic anti-Fas MAb (clonemice exhibit defective expansion of cells but that only
Jo2, no sodium azide, low endotoxin; PharMingen; Ogasawara etIL-2±deficient mice exhibit defective deletion suggests
al., 1993) or purified hamster IgG (PharMingen) as a control. Second,
that Stat5a plays a vital role in expansion but not in splenocytes were cultured for 6 hr with soluble FasL (100 ng/ml)
FasL-mediated deletion and that Stat5a-independent with 1 mg/ml of an enhancer of FasL-mediated killing (Alexis, San
Diego, CA) according to the manufacturer's instructions. Cells werepathways are responsible for the differences in deletion.
then harvested, stained with anti-Vb8 FITC, and either anti-CD4Finally, these mice provide insight into the immunologi-
CyChrome or anti-CD8 CyChrome. Cell viability was determinedcal phenotype that might be seen in humans with Stat5a
using PI and a flow cytometer, without gating. The percentage Fas-
deficiency, an important consideration in the treatment induced cell death of CD41 Vb81 T cells was calculated as (1 2
of patients with primary immunodeficiencies associated [number of CD41 Vb81 PI2 cells in the experimentalculture]/[number
of CD41 Vb81 PI2 cells in the control culture]) 3 100. Analogously,with normal numbers of T and B cells.
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the percentage Fas-induced cell death of CD81 Vb81 T cells was pan-Stat5 antibody, T. R. Malek for the murine IL-2Rb cDNA, J. F.
Mushinski for the murine bcl-2 cDNA, J. Hu-Li for measuring IL-2calculated.
levels, and S. John for critical comments. H. N. was supported in
part by Japan Society for the Promotion of Science and The NaitoPreactivation of Splenocytes
Foundation.Splenocytes (1 3 106/ml) were stimulated in Falcon 3003 plates
coated with 10 mg/ml anti-CD3e MAb (145±2C11, PharMingen) or
phytohemagglutinin in RPMI 1640 medium containing 10% FBS, 2 Received March 14, 1997; revised August 13, 1997.
mM glutamine, and antibiotics for 48 hr.
ReferencesIL-2 Production and Proliferation Assays
For IL-2 production, splenocytes were cultured for 48 hr in Falcon
Ascherman, D.P., Migone, T.-S., Friedmann, M.C., andLeonard, W.J.3003 plates coated with 10 mg/ml anti-CD3e MAb (145±2C11), and
(1997). IL-2-mediated induction of the IL-2 receptor a chain gene:IL-2 was measured by bioassay as described previously (Cao et al.,
critical role of two functionally redundant tyrosine residues in the1995). For proliferation of fresh splenocytes, 96-well plates were
IL-2 receptor b chain cytoplasmic domain and suggestion that thesecoated with 10 mg/ml anti-CD3e MAb. Splenocytes (2 3 105/well)
residues mediate more than Stat5 activation. J. Biol. Chem. 272,were cultured for 48 hr, with 1 mCi of [3H]thymidine added for the
8704±8709.final 10 hr. For proliferation of anti-CD3±stimulated splenocytes,
Azam, M., Erdjument-Bromage, H., Kreider, B.L., Xia, M., Quelle, F.,cells (1 3 105) were cultured with various concentration of IL-2
Basu, R., Saris, C., Tempst, P., Ihle, J.N., and Schindler, C. (1995).(Cetus) for 24 hr with a [3H]thymidine pulse for the last 10 hr.
Interleukin-3 signals through multiple isoforms of Stat5. EMBO J.
14, 1402±1411.Northern Blotting
Bamford, R.N., Grant, A.J., Burton, J.D., Peters, C., Kurys, G., Gold-Anti-CD3±stimulated splenocytes were cultured with or without 2
man, C.K., Brennan, J., Roessler, E., and Waldmann, T.A. (1994).nM human recombinant IL-2 for 10 hr. Cells were washed with PBS,
The interleukin (IL)-2 receptor beta chain is shared by IL-2 and aand RNA was extracted using Trizol reagent (Gibco BRL). Northern
cytokine, provisionally designated IL-T, that stimulates T cell prolif-blotting was performed using 18 mg of total RNA by standard meth-
eration and the induction of lymphokine activated killer cells. Proc.ods, as previously described (Ascherman et al., 1997). Blots were
Natl. Acad. Sci. USA 92, 4940±4944.hybridized with the following probes: a 1.2 kb fragment of murine
IL-2Ra cDNA (Miller et al., 1985), a 1.7 kb fragment of murine IL-2Rb Beadling, C., Guschin, D., Witthuhn, B.A., Ziemiecki, A., Ihle, J.N.,
cDNA (a gift from T. Malek), a 2.2 kb fragment of murine Bcl-2 cDNA Kerr, I.M., and Cantrell, D.A. (1994). Activation of JAK kinases and
(a gift from J. F. Mushinski), a 0.5 kb polymerase chain reaction STAT proteins by interleukin-2 and interferon a, but not the T cell
(PCR)±generated fragment of the murine IL-2 cDNA, and a 1.0 kb antigen receptor, in human T lymphocytes. EMBO J. 13, 5605±5615.
PCR fragment of the murine glyceraldehyde-3-phosphate dehy- Cao, X., Shores, E.W., Hu-Li, J., Anver, M.R., Kelsall, B.L., Russell,
drogenase (G3PDH) cDNA (Ascherman et al., 1997). Probes were S.M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E.T., Paul, W.E.,
labeled by random priming using the Prime It II Kit (Stratagene). Katz, S.I., Love, P.E., and Leonard, W.J. (1995). Defective lymphoid
development in mice lacking expression of the common cytokine
Electrophoretic Mobility Shift Assays receptor g chain. Immunity 2, 223±238.
A probe derived from the ovine b-casein promoter was labeled with
Depper, J.M., Leonard, W.J., Drogula, C., Kronke, M., Waldmann,[32P]dGTP and Klenow fragment of DNA polymerase, as previously
T.A., and Greene, W.C. (1985). Interleukin 2 (IL-2) augments tran-described (Lin et al., 1996). Cells were washed twice with PBS,
scription of the IL-2 receptor gene. Proc. Natl. Acad. Sci. USA 82,resuspended in lysis buffer (20 mM HEPES [pH 7.8], 450 mM NaCl,
4230±4234.0.4 mM EDTA, 0.5 mM dithiothreitol, 25% glycerol, 0.5 mM AEBSF
DiSanto, J.P, MuÈ ller, W., Guy-Grand, D., Fischer, A., and Rajewsky,(4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride), and pro-
K. (1995). Lymphoid development in mice with a targeted deletiontease inhibitors), and subjected to three freeze±thaw cycles. Whole-
of the interleukin-2 receptor g chain. Proc. Natl. Acad. Sci. USA 92,cell extracts were prepared by spinning at 18,000 3 g at 48C for 15
377±381.min. Samples (12 mg) of extract in 10 ml of lysis buffer was combined
with 11 ml of 23 binding buffer (100 mM KCl, 20 mM Tris-HCl, 20 Durbin, J.E., Hackenmiller, R., Simon, M.C., and Levy, D.E. (1996).
Targeted disruption of the mouse Stat1 gene results incompromisedmM HEPES, 1 mM dithiothreitol, 1 mM EDTA, 20% glycerol [pH 7.8])
containing 2 mg of poly dI-dC and incubated for 20 min on ice, and innate immunity to viral disease. Cell 84, 443±450.
then 3 3 104 cpm of the probe was added and incubation continued Feldman, G.M., Rosenthal, L.A., Liu, X., Hayes, M.P., Wynshaw-
on ice for an additional 20 min. Supershifting was performed by Boris, A., Leonard, W.J., Hennighausen, L., and Finbloom, D.S.
preincubating the whole-cell extract with 3 ml of a pan-Stat5 antise- (1997). STAT5A-deficient mice demonstrate a defect in granulocyte-
rum that recognizes both Stat5a and Stat5b(Lin et al., 1995). Electro- macrophage colony-stimulating factor-induced proliferation and
phoresis was carried out at room temperature using 5% or 6% gene expression. Blood 90, 1768±1776.
polyacrylamide gels. Friedmann, M.C., Migone, T.S., Russell, S.M., and Leonard, W.J.
(1996). Different interleukin 2 receptor b-chain tyrosines couple to
Western Blotting at least two signaling pathways and synergistically mediate interleu-
Samples (15 mg) of whole cell extracts were separated on 8% SDS kin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 93, 2077±
polyacrylamide gels and transferred to Immobilon-P membranes 2082.
(Millipore). Blots were blocked with PBS containing 0.15% Tween
Fujii, H., Nakagawa, Y., Schindler, U., Kawahara, A., Mori, H., Gouil-20 and 3% BSA for 1 hr at room temperature and incubated with
leux, F., Groner, B., Ihle, J.N., Minami, Y., Miyazaki, T., et al. (1995).anti-Stat5a (Liu et al., 1996), anti-Stat5b (Liu et al., 1996), or anti-
Activation of Stat5 by interleukin 2 requires a carboxyl-terminal re-Stat3 (Transduction Laboratories) for 1 hr at room temperature. After
gion of the interleukin 2 receptor b chain but is not essential forthree washes of 10 min each with PBS containing 0.15% Tween
the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92,20, blots were incubated with anti-mouse or anti-rabbit antibodies
5482±5486.conjugated with horseradish peroxidase (Amersham) in PBS con-
Gaffen, S.L., Lai, S.Y., Xu, W., Gouilleux, F., Groner, B., Goldsmith,taining 0.15% Tween 20 and 3% BSA for 1 hr at room temperature;
M.A., and Greene, W.C. (1995). Signaling through the interleukin 2washed with PBS containing 0.15% Tween 20; and developed with
receptor b chain activates a STAT-5-like DNA-binding activity. Proc.an enhanced chemiluminescent substrate (Pierce).
Natl. Acad. Sci. USA 92, 7192±7196.
Gilmour, K., Pine, R., and Reich, N.C. (1995). Interleukin 2 activatesAcknowledgments
STAT5 transcription factor (mammary gland factor) and specific
gene expression in T lymphocytes. Proc. Natl. Acad. Sci. USA 92,We thank M. Noguchi and D. P. Ascherman for providing probes,
G. Feldman for valuable discussions, J.-X. Lin for providing the 10772±10776.
Immunity
700
Giri, J.G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to
Kumaki, S., Namen, A., Park, L.S., Cosman, D., and Anderson, D. mammary gland differentiation. Mol. Endocrinol. 10, 1496±1506.
(1994). Utilization of the b and g chains of the IL-2 receptor by the Liu, X., Robinson, G.W., Wagner, K-U., Garrett, L., Wynshaw-Boris,
novel cytokine IL-15. EMBO J. 13, 2822±2830. A., and Hennighausen, L. (1997). Stat5a is mandatory for adult mam-
Goldsmith, M.A., Lai, S.Y., Xu, W., Amaral, C., Kuczek, E.S., Parent, mary gland development and lactogenesis. Genes Dev. 11, 179±186.
L.J., Mills, G.B., Tarr, K.L., Longmore, G.D., and Greene, W.C. (1995). Meraz, M.A., White, J.M., Sheehan, K.C., Bach, E.A., Rodig, S.J.,
Growth signal transduction by the human interleukin-2 receptor re- Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell,
quires cytoplasmic tyrosines of the b chain and non-tyrosine resi- D., et al. (1996). Targeted disruption of the Stat1 gene in mice reveals
dues of the gc chain. J. Biol. Chem. 270, 21729±21737. unexpected physiologic specificity in the JAK-STAT signaling path-
Horvath, C.M., and Darnell, J.E., Jr. (1997). The state of STATs: way. Cell 84, 431±442.
recent developments in the study of signal transduction to the nu- Migliorati, G., Nicoletti, I., Pagliacci, M.C., D'Adamio, L., and Ric-
cleus. Curr. Opin. Cell Biol. 9, 233±239. cardi, C. (1993). Interleukin-4 protect double-negative and CD4 sin-
Hou, J., Schindler, U., Henzel, W.J., Wong, S.C., and McKnight, gle positive thymocytes from dexamethasone-induced apoptosis.
S.L. (1995). Identification and purification of human Stat proteins Blood 81, 1352±1358.
activated in response to interleukin-2. Immunity 2, 321±329. Miller, J., Malek, T.R., Leonard, W.J., Greene, W.C., Shevach, E.M.,
Ihle, J.N. (1996). STATs: signal transducers and activators of tran- and Germain, R.N. (1985). Nucleotide sequence and expression of
scription. Cell 84, 331±334. a mouse interleukin 2 receptor cDNA. J. Immunol. 134, 4212±4217.
John, S., Reeves, R.B., Lin, J.-X., Child, R., Leiden, J.M., Thompson, Mui, A.L., Wakao, H., Kinoshita, T., Kitamura, T., and Miyajima, A.
C.B., and Leonard, W.J. (1995). Regulation of cell-type-specific in- (1995a). Suppression of interleukin-3-induced gene expression by
terleukin-2 receptor a-chain gene expression: potential role of physi- a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J.
cal interactions between Elf-1, HMG-I(Y), and NF-kB family proteins. 15, 2425±2433.
Mol. Cell. Biol. 15, 1786±1796. Mui, A.L., Wakao, H., O'Farrell, A.M., Harada, N., and Miyajima, A.
John, S., Robbins, C.M., and Leonard, W.J. (1996). An IL-2 response (1995b). Interleukin-3, granulocyte-macrophage colony stimulating
element in the human IL-2 receptor a chain promoter is a composite factor and interleukin-5 transduce signals through two STAT5 homo-
element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. logs. EMBO J. 14, 1166±1175.
EMBO J. 15, 5627±5635. Nakamura, Y., Russell, S.M., Mess, S.A., Friedmann, M., Erdos, M.,
Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996a). Francois, C., Jacques, Y., Adelstein, S., and Leonard, W.J. (1994).
Stat6 is required for mediating responses to IL-4 and for develop- Heterodimerization of the IL-2 receptor b- and g-chain cytoplasmic
ment of Th2 cells. Immunity 4, 313±319. domains is required for signalling. Nature 369, 330±333.
Kaplan, M.H., Sun, Y.L., Hoey, T., andGrusby, M.J. (1996b). Impaired Negishi, I., Motoyama, N., Nakayama, K., Nakayama, K., Senju, S.,
IL-12 responses and enhanced development of Th2 cells in Stat4- Hatakeyama, S., Zhang, Q., Chan, A.C., and Loh, D.Y. (1995). Essen-
deficient mice. Nature 382, 174±177. tial role for ZAP-70 in both positive and negative selection of thymo-
cytes. Nature 376, 435±438.Kawabe, Y., and Ochi, A. (1991). Programmed cell death and ex-
trathymic reduction of Vb81CD41 T cells in mice tolerant to Staphy- Nelson, B.H., Lord, J.D., and Greenberg, P.D. (1994). Cytoplasmic
lococcus aureus enterotoxin B. Nature 349, 245±248. domains of the interleukin-2 receptor b and g chains mediate the
signal for T-cell proliferation. Nature 369, 333±336.Kneitz, B., Herrmann, T., Yonehara, S., and Schimpl, A. (1995). Nor-
mal clonal expansion but impaired Fas-mediated cell death and Nosaka, T., van Deursen, J.M., Tripp, R.A., Thierfelder, W.E., Witt-
anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. huhn, B.A., McMickle, A.P., Doherty, P.C., Grosveld, G.C., and Ihle,
25, 2572±2577. J.N. (1995). Defective lymphoid development in mice lacking Jak3.
Science 270, 800±802.Lecine, P., Algarte, M., Rameil, P., Beadling, C., Bucher, P., Nabholz,
M., and Imbert, J. (1996). Elf-1 and Stat5 bind to a critical element Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa,
in a new enhancer of the human interleukin-2 receptor a gene. Mol. A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993).
Cell. Biol. 16, 6829±6840. Lethal effect of anti-Fas antibody in mice. Nature 364, 806±809.
Leonard, W.J. (1996). STATs and cytokine specificity. Nature Med. Ohbo,K., Suda, T., Hashiyama, M.,Mantani, A., Ikebe, M.,Miyakawa,
2, 968±969. K., Moriyama, M., Nakamura, M., Katsuki, M., Takahashi, K., et al.
(1996). Modulation of hematopoiesis in mice with a truncated mutantLeonard, W.J., and O'Shea, J.J. (1998). Jaks and STATs: biological
of the interleukin-2 receptor g chain. Blood 87, 956±969.implications. Annu. Rev. Immunol., in press.
Park, S.Y., Saijo, K., Takahashi, T., Osawa, M., Arase, H., Hirayama,Leonard, W.J., Depper, J.M., Crabtree, G.R., Rudikoff, S., Pumphrey,
N., Miyake, K., Nakauchi, H., Shirasawa, T., and Saito, T. (1995).J., Robb, R.J., Kronke, M., Svetlik, P.B., Peffer, N.J., Waldmann,
Developmental defects of lymphoid cells in Jak3 kinase-deficientT.A., et al. (1984). Molecular cloning and expression of cDNAs for
mice. Immunity 3, 771±782.the human interleukin-2 receptor. Nature 311, 625±631.
Peschon, J.J., Morrissey, P.J., Grabstein, K.H., Ramsdell, F.J.,Leonard, W.J., Noguchi, M.,Russell, S.M., and McBride,O.W. (1994).
Maraskovsky, E., Gliniak, B.C., Park, L.S., Ziegler, S.F., Williams,The molecular basis of X-linked severe combined immunodefi-
D.E., Ware, C., et al. (1994). Early lymphocyte expansion is severelyciency: the role of the interleukin-2 receptor g chain as a common
impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180,g chain, gc. Immunol. Rev. 138, 61±86.
1955±1960.Lin, J.-X., Migone, T.S., Tsang, M., Friedmann, M., Weatherbee, J.A.,
Quelle, F.W., Wang, D., Nosaka, T., Thierfelder, W.E., Stravopodis,Zhou, L., Yamauchi, A., Bloom, E.T., Mietz, J., John, S., et al. (1995).
D., Weinstein, Y., and Ihle, J.N. (1996). Erythropoietin induces activa-The role of shared receptor motifs and common Stat proteins in the
tion of Stat5 through association with specific tyrosines on the re-generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7,
ceptor that are not required for a mitogenic response. Mol. Cell.IL-13, and IL-15. Immunity 2, 331±339.
Biol. 16, 1622±1631.Lin, J.-X., Migone, T.S., Tsang, M., Friedmann, M., Weatherbee, J.A.,
Sadlack, B., Lohler, J., Schorle, H., Klebb, G., Haber, H., Sickel, E.,Lin, J.-X., Mietz, J., Modi, W.S., John, S., and Leonard, W.J. (1996).
Noelle, R.J., and Horak, H. (1995). Generalized autoimmune diseaseCloning of human Stat5B: reconstitution of interleukin-2-induced
in interleukin-2-deficient mice is triggered by an uncontrolled activa-Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol.
tion and proliferation of CD41 T cells. Eur. J. Immunol. 25, 3053±Chem. 271, 10738±10744.
3059.Liu, X., Robinson, G.W., Gouilleux, F., Groner, B., and Hennighausen,
Schindler, C., and Darnell, J.E., Jr. (1995). Transcriptional responsesL. (1995). Cloning and expression of Stat5 and an additional homo-
to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Bio-logue (Stat5b) involved in prolactin signal transduction in mouse
chem. 64, 621±651.mammary tissue. Proc. Natl. Acad. Sci. USA 92, 8831±8835.
Liu, X., Robinson, G.W., and Hennighausen, L. (1996). Activation of Sharfe, N., Dadi, H.K., Shahar, M., and Roifman, C.M. (1997). Human
Indirect Role for Stat5a in Proliferation
701
immune disorder arising from mutation of the a chain of the interleu-
kin-2 receptor. Proc. Natl. Acad. Sci. USA 94, 3168±3171.
Shimoda, K.,van Deursen, J., Sangster, M.Y., Sarawar, S.R., Carson,
R.T., Tripp, R.A., Chu, C., Quelle, F.W., Nosaka, T., Vignali, D.A., et al.
(1996). Lack of IL-4-induced Th2 response and IgE class switching in
mice with disrupted Stat6 gene. Nature 380, 630±633.
Smith, K.A. (1988). Interleukin-2: inception, impact, and implications.
Science 240, 1169±1176.
Sperisen, P., Wang, S.M., Soldaini, E., Pla, M., Rusterholz, C.,
Bucher, P., Corthesy, P., Reichenbach, P., and Nabholz, M. (1995).
Mouse interleukin-2 receptor a gene expression: interleukin-1 and
interleukin-2 control transcription via distinct cis-acting elements.
J. Biol. Chem. 270, 10743±10753.
Stocklin, E., Wissler, M., Gouilleux, F., and Groner, B. (1996). Func-
tional interactions between Stat5 and the glucocorticoid receptor.
Nature 383, 726±728.
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashi-
wamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S.
(1996). Essential role of Stat6 in IL-4 signalling. Nature 380, 627±630.
Thierfelder, W.E., van Deursen, J.M., Yamamoto, K., Tripp, R.A.,
Sarawar, S.R., Carson, R.T., Sangster, M.Y., Vignali, D.A., Doherty,
P.C., Grosveld, G.C., et al. (1996). Requirement for Stat4 in interleu-
kin-12-mediated responses of natural killer and T cells. Nature 382,
171±174.
Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.H., and Berg, L.J.
(1995). Defects in B lymphocyte maturation and T lymphocyte acti-
vation in mice lacking Jak3. Science 270, 794±797.
Udy, G.B., Towers, R.P., Snell, R.G., Wilkins, R.J., Park, S.-H., Ram,
P.A., Waxman,D.J., and Davey, H.W. (1997). Requirement of STAT5b
for sexual dimorphism of body growth rates and liver gene expres-
sion. Proc. Natl. Acad. Sci. USA 94, 7239±7244.
von Freeden-Jeffry, U., Vieira, P., Lucian, L.A., McNeil, T., Burdach,
S.E., and Murray, R. (1995). Lymphopenia in interleukin (IL)-7 gene-
deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp.
Med. 181, 1519±1526.
Wakao, H., Gouilleux, F., and Groner, B. (1994). Mammary gland
factor (MGF) is a novel member of the cytokine regulated transcrip-
tion factor gene family and confers the prolactin response. EMBO
J. 13, 2182±2191.
Wakao, H., Harada, N., Kitamura, T., Mui, A.L., and Miyajima, A.
(1995). Interleukin 2 and erythropoietin activate STAT5/MGF via dis-
tinct pathways. EMBO J. 14, 2527±2535.
Willerford, D.M., Chen, J., Ferry, J.A., Davidson, L., Ma, A., and Alt,
F.W. (1995). Interleukin-2 receptor a chain regulates the size and
content of the peripheral lymphoid compartment. Immunity 3,
521±530.
Zuniga-Pflucker, J.C., Di, J., and Lenardo, M.J. (1996). Requirement
for TNF-a and IL-1 a in fetal thymocyte commitment and differentia-
tion. Science 268, 1906±1909.
